�鶹Ů��

Georgia Gov. Brian Kemp’s new health plan for low-income adults has enrolled only 1,343 people through the end of September about three months after launching, The Atlanta Journal-Constitution reports. The Georgia Department of Community Health has projected up to 100,000 people could eventually benefit from Georgia Pathways to Coverage. But the nation’s only Medicaid program that makes recipients meet a work requirement is off to a very slow start. (10/20)

Six months in, the nationwide effort to cull ineligible beneficiaries from the Medicaid rolls has proven to be as messy and consequential as predicted. More than 9 million people have lost Medicaid coverage since states resumed eligibility checks in April after pausing them during the COVID-19 public health emergency. That's more than halfway toward the 15 million the Health and Human Services Department projected. And the vast majority of disenrollments are the result of procedural matters—states being unable to reach Medicaid beneficiaries, people returning incomplete forms and so on—not the result of states affirmatively identifying the people no longer qualify for coverage. (Berryman, 10/23)

Pennsylvania was among a few dozen states to report a problem in the way they conducted eligibility checks, automatically disqualifying entire families if they found one person was no longer eligible. With children being more likely to qualify for Medicaid due to more generous eligibility thresholds, the error is expected to disproportionately hurt this group. The scope of the problem in Pennsylvania remains uncertain as DHS works to re-evaluate cases at an individual level. (Anderson, 10/23)

Pennsylvania is struggling with faulty technology, persistent staffing shortages, and flawed procedures as it reassesses health care coverage for hundreds of thousands of adults and children. All states were required to begin reevaluating who qualifies for Medicaid and the Children's Health Insurance Program, or CHIP, in April as part of the “unwinding” of pandemic-era rules that allowed for continuous coverage. (Meyer, 10/23)

A new report reveals Medicaid issues facing thousands of New Mexicans. Nearly 100,000 locals have been unenrolled due to changing eligibility requirements and issues plague remaining customers, according to a report by the Legislative Finance Committee (LFC). (Segarra, 10/20)

Oleta Fitzgerald and the Children’s Defense Fund have been trying to fill in some of the gaps but admit they don’t have the resources or reach of the government. “Most of the outreach that has gone on from the state levels has been through the internet,” she noted. “And a lot of people do not have access to the internet. So, we have to engage in different strategies to reach these families.” (Jackson, 10/19)

About 76,000 people have been removed from the MassHealth rolls since March, and officials continue to forecast the biggest impacts are around the corner as a massive reevaluation of eligibility ramps up this fall. MassHealth published the latest monthly summary of its year-long redetermination effort Friday, showing that another 48,000 people lost MassHealth coverage in September. That was offset by about 18,000 new enrollees and 6,300 people who rejoined the publicly funded health insurance program after previously losing coverage. (10/22)

As eligibility for dental benefits increases in the state, the University of Iowa College of Dentistry is seeing an influx of Medicaid patients from private dentist offices. Iowa has seen a 1.63 percent increase in Medicaid patients in the last year with 13,351 new members. The total number as of May 2023 was 833,203. UI College of Dentistry Dean Clark Stanford views the increase as a positive and said for Medicaid patients in particular, the university is the principal source for specialty care in the state. (Reddy, 10/22)

Federal law that prohibits insurers from denying healthcare based on preexisting conditions, or kicking dependents off their parent’s coverage until age 26, is now codified separately into Michigan law. Democratic Gov. Gretchen Whitmer signed legislation Thursday that attempts to duplicate the Affordable Care Act, known as “Obamacare,” into state law. The second-term governor said earlier this year that the proactive move was necessary to ensure Michigan residents “aren’t at risk of losing coverage,” due to future Supreme Court rulings. (Cappelletti, 10/20)

The U.S. Food and Drug Administration (FDA) has approved Pfizer's vaccine Penbraya, making it the first shot to protect against five groups of a deadly bacteria that can cause meningitis and blood poisoning, the company said on Friday. Meningococcal diseases are rare bacterial infections that commonly affect the brain, spinal cord and bloodstream, and can be deadly in a matter of hours. (10/20)

French drugmaker Sanofi said on Friday it was seeing an "unprecedented level" of demand for an antibody therapy it co-developed to prevent respiratory syncytial virus (RSV), a leading cause of hospitalizations in infants. The therapy, branded Beyfortus and jointly developed by Sanofi and AstraZeneca, was approved in July to prevent RSV in infants and toddlers. (10/21)

So what is brewing in the viral stew? There's the big three to start: the flu, respiratory syncytial virus (RSV) and COVID-19. "These are the three that cause the most utilization of the health care system and the most severe disease," says Dr. Demetre Daskalakis, acting director of the Centers for Disease Control and Prevention's National Center for Immunization and Respiratory Diseases. ... And there are other viruses in the mix, says Marlene Wolfe, an epidemiologist and assistant professor at Emory University. (Huang, 10/21)

Flu activity in the United States is low and remains well below baselines, but some parts of the country are experiencing slight rises, the Centers for Disease Control and Prevention (CDC) said today in its latest weekly update. The percentage of respiratory specimens that tested positive for flu at clinical labs rose last week in region 8, which includes Colorado, Montana, North Dakota, South Dakota, Utah, and Wyoming. Levels remained stable in other parts of the country. (Schnirring, 10/20)

Flu and cold season has arrived early in Alaska this year, prompting reminders from public health officials about the importance of getting yearly influenza vaccines, and soon. “We’re definitely having a busier, earlier flu season than we have in recent years,” said Anna Frick, an epidemiologist with the Alaska Department of Health. “It’s here, it’s in multiple parts of the state, and seems to be on the rise. So now is a great time to go get that shot,” she said. (Berman, 10/22)

America’s drug overdose crisis is out of control. Washington, despite a bipartisan desire to combat it, is finding its addiction-fighting programs are failing. In 2018, Republicans, Democrats and then-President Donald Trump united around legislation that threw $20 billion into treatment, prevention and recovery. But five years later, the SUPPORT Act has lapsed and the number of Americans dying from overdoses has grown more than 60 percent, driven by illicit fentanyl. The battle has turned into a slog. (Paun, 10/22)

Prisons are supposed to be secure, drug-free zones that support rehabilitation. But an Atlanta Journal-Constitution investigation has uncovered a spike in overdose deaths that reveals in startling terms the prevalence of illicit drugs inside Georgia’s prisons. ... So far this year, medical examiners have determined that five inmates have died from accidental overdoses, but they have yet to rule on the causes of many other prison deaths. (Robbins and Teegardin, 10/20)

In 2019, the state of Texas gave out more than 230,000 doses of naloxone, a life saving medicine that can reverse opioid overdoses, through its More Narcan Please program. More than three years later, that medication, in the form of a nasal spray known as Narcan, is past the expiration date printed on its label. For some organizations, that expired Narcan is gold. (Buch, 10/23)

City outreach workers are knocking on thousands of doors to give lifesaving overdose reversal drugs directly to residents in North Philadelphia neighborhoods, where overdose deaths have been rising sharply and people often lack access to addiction resources. Outreach workers from the city’s community engagement arm, Philly Counts, have been fanning out through the 19140 zip code, where 85 people died of overdoses in 2022. (Whelan, 10/21)

A doctor, a patient advocate, and the most powerful figure in the methadone treatment industry presented competing visions for the future of American addiction medicine this week — a conversation that touched on stigma, patients’ rights, and a stark divide in health provider attitudes toward patients with addiction. (Facher, 10/20)

�鶹Ů�� Health News: Using Opioid Settlement Cash For Police Gear Like Squad Cars And Scanners Sparks Debate

Policing expenses mount quickly: $25,000 for a law enforcement conference about fentanyl in Colorado; $18,000 for technology to unlock cellphones in Southington, Connecticut; $2,900 for surveillance cameras and to train officers and canines in New Lexington, Ohio. And in other communities around the country, hundreds of thousands for vehicles, body scanners, and other equipment. In these cases and many others, state and local governments are turning to a new means to pay those bills: opioid settlement cash. (Pattani, 10/23)

The Navy's Special Warfare Command is poised to begin regularly testing all Navy SEALs for performance-enhancing drugs next month, but the effort to root out the potentially dangerous substances could also lead the service into a legal minefield. The move is being presented as a reasonable safety measure by the Navy following a highly publicized sailor death, reports of widespread abuse of the drugs in the SEAL training program, and damning investigations that painted a picture of instructors showing little regard for the safety of recruits -- often pushing them beyond their physical limits. (Toropin, 10/20)

Some of the most high-profile artificial intelligence chatbots churned out responses that perpetuated false or debunked medical information about Black people, a new study found. As AI takes off, chatbots are already being incorporated into medicine — with little to no oversight. These new tech tools, if fueled by false or inaccurate data, have the potential to worsen health disparities, experts have warned. (Goldman, 10/23)

Generative AI tools are already helping doctors transcribe visits and summarize patient records. The technology behind ChatGPT, trained on vast amounts of data from the internet, made headlines when it correctly answered more than 80% of board exam questions. In July, a team at Beth Israel saw promising results when using GPT-4 during a diagnosis workshop for medical residents. (Lawrence, 10/20)

The Food and Drug Administration on Thursday released a new accounting of artificial intelligence tools cleared for use in health care, adding scores of new products designed to reshape care in several areas of medicine. (Ross and Palmer, 10/20)

Around 700 frontline healthcare workers at Providence St. Joseph Medical Center in Burbank, California, plan to strike Monday over claims that the system is bargaining in bad faith. The strike is set to run Monday through Friday and will include lab technicians, phlebotomists, patient transporters and other staff represented by SEIU-United Healthcare Workers West. (Devereaux, 10/20)

Organized labor is having a moment, and doctors and support staff in the nation's hospitals want in on it. While those groups of workers have historically been less engaged in union activity than their nurse colleagues, they are expressing an unprecedented level of interest in organizing. (Devereaux, 10/20)

Fifty doctors, including a former member of the board of directors of Mission Hospital and a former chief of staff, have written a letter condemning what they say is HCA Healthcare’s “for-profit-driven” management after buying the nonprofit hospital system in 2019 for $1.5 billion. (Jones, 10/22)

Blue Cross and Blue Shield of North Carolina has struck a deal to acquire 55 urgent care centers from FastMed, the insurer announced Friday. The nonprofit carrier plans to ramp up FastMed operations in North Carolina after a downturn related to the COVID-19 pandemic, in part by boosting hiring. The parties did not disclose the terms of the sale agreement. (Berryman, 10/20)

The Hospital of the University of Pennsylvania is in line to receive $86 million from the government under a legal settlement resolving cuts made to a national drug discount program designed to strengthen safety-net hospitals. The amount for Penn’s flagship hospital in University City amounts to the sixth-largest payout to any hospital in the nation, and accounts for the bulk of the $129.2 million coming to the University of Pennsylvania Health System, according to the Centers for Medicare and Medicaid Services. (Brubaker, 10/23)

�鶹Ů�� Health News: Tiny, Rural Hospitals Feel The Pinch As Medicare Advantage Plans Grow 

Jason Bleak runs Battle Mountain General Hospital, a small facility in a remote Nevada gold mining town that he described as “out here in the middle of nowhere.” When several representatives from private health insurance companies called on him a few years ago to offer Medicare Advantage plan contracts so their enrollees could use his hospital, Bleak sent them away. “Come back to the table with a better offer,” the chief executive recalled telling them. The representatives haven’t returned. (Tribble, 10/23)

A team of researchers from the University of Missouri is working to address a longstanding issue on the battlefield—antibiotic resistant superbugs in combat wounds. Hongmin Sun, an associate professor of cardiovascular medicine at MU, and her team received a $1.2 million grant from the U.S. Army. Sun, who is leading the research, said many of the drug resistant infections require medical professionals to use strong antibiotics to treat them. (Lewis-Thompson, 10/23)

The annual meeting of the American Society of Reproductive Medicine is usually a buoyant, shiny parade of new science, fresh technology products, and promises that together they will provide more people with more options than ever before for taking control of how and when, and if, they have children. (Molteni, 10/20)

A Roche drug lowered the risk of recurrence or death by 76% versus chemotherapy for patients with a type of early non-small cell lung cancer, according to data from a Phase 3 trial presented Saturday. (Joseph, 10/21)

Roche Holding has agreed to buy Telavant Holdings from Roivant Sciences and Pfizer in a deal worth up to $7.25 billion as the Swiss pharmaceutical giant seeks to bolster its immunology pipeline. The acquisition will give Roche rights over Telavant’s drug candidate that has shown promise for inflammatory bowel disease and could have potential in other indications, it said. Roche will have rights to commercialize the drug in the U.S. and Japan, pending clinical-trial data and regulatory approval. (Calatayud, 10/23)

After decades of expansion, the nation’s largest drugstore chains are closing hundreds of stores as they reorient their operations against rising competition, a crush of opioid lawsuits and other forces — relegating many already-vulnerable communities into pharmacy deserts. Rite Aid, which filed for Chapter 11 bankruptcy protection last week, CVS and Walgreens have signaled over the past two years plans to collectively shutter more than 1,500 stores. Public health experts have already seen the fallout, noting that the first neighborhoods to lose their pharmacies are often predominantly Black, Latinx and low-income. (Gregg and Peiser, 10/22)

A group of pharmacies has filed a proposed class action lawsuit accusing Cigna Group's pharmacy benefit manager unit Express Scripts Inc of conspiring with another company to charge higher fees and reimburse pharmacies at lower rates. In a complaint filed Thursday in federal court in Milwaukee, Wisconsin, four retail pharmacies said that a three-year collaboration agreement announced in 2019 between Express Scripts and Prime Therapeutics was in fact a pretext for fixing reimbursement rates and fees, with no benefit for customers. (Pierson, 10/20)

Pharmacists increasingly are being asked to make drugs in bulk for hospitals that are in short supply, and they’re even beginning to make chemotherapies. But some in the industry worry about the unintended consequences of overreliance. Hospitals’ reliance on pharmacist-made drugs, a practice called compounding, has risen in step with worsening drug shortages. (Wilkerson, 10/20)

It's well known that having obesity increases the risk of a wide range of health conditions, but data suggests it may not be just the extra weight that adds risk. Medications may not work as well on people with obesity, studies suggest, because, although people with a lot of body fat metabolize drugs differently, they aren't required to be included in research trials. So prescribed doses may be too high in some cases and linger too long in others. (Weintraub, 10/22)

The drugs’ list prices are generally very different from the net prices, which companies receive after making secret deals with health insurers or the intermediaries known as pharmacy benefit managers. Companies generally do not reveal net prices, but there are data sources that can be used to estimate them. (Kolata, 10/22)

�鶹Ů�� Health News: Quick Genetic Test Offers Hope For Sick, Undiagnosed Kids. But Few Insurers Offer To Pay. 

Just 48 hours after her birth in a Seattle-area hospital in 2021, Layla Babayev was undergoing surgery for a bowel obstruction. Two weeks later, she had another emergency surgery, and then developed meningitis. Layla spent more than a month in neonatal intensive care in three hospitals as doctors searched for the cause of her illness. (Galewitz, 10/23)

A great deal of emphasis is placed on the emotional and mental impact of dementia — but a new study from the University of Michigan highlights the financial burden it puts on families as well. Among people who were diagnosed with dementia, out-of-pocket health care costs more than doubled within the first eight years, researchers found. Dementia patients also experienced more than a 60% reduction in their net worth, according to the study findings, which were published in JAMA Internal Medicine. (Rudy, 10/23)

Having a baby is expensive in the U.S. — and it’s getting costlier. The median cost for an in-network C-section in the U.S. last year was about $15,500, while the median cost of a vaginal birth with no complications was almost $13,000, according to FAIR Health’s cost of giving birth tracker.   And the national median price for an out-of-network birth is more than twice as expensive, according to the tracker.    (O'Connell-Domenech, 10/22)

Service members now can file claims related to alleged malpractice at military medical facilities for up to $750,000, after the Pentagon proposed an increase from the previous limit of $600,000. Pentagon Press Secretary Brig. Gen. Pat Ryder announced in an email to media outlets that the proposed change applies "to any pending claims" and was published in the Federal Register on Friday. (Novelly and Kheel, 10/20)

A Mediterranean diet that's rich in vegetables, fruits and fish may help reduce or stave off symptoms of post-traumatic stress disorder, according to research published this week in the journal Nature Mental Health. The peer-reviewed findings are based on patient data from two studies — one in 2008 and another in 2013 — which collectively involved tens of thousands of female participants. The researchers behind those studies gathered stool samples, as well as information about the women's mental health and dietary habits. (Bendix, 10/22)

A new study in Colorado is trying to answer definitively whether psychedelics help at least some patients dealing with distress over advanced cancer. Dr. Stacy Fischer, co-leader of cancer prevention and control at the University of Colorado Cancer Center, said several small studies have found that psychedelic drugs may help patients who are experiencing demoralization or despair because of their impending mortality. (Wingerter, 10/20)

It’s been a month since a Maryland man became the second person to receive a transplanted heart from a pig –- and hospital video released Friday shows he’s working hard to recover. Lawrence Faucette was dying from heart failure and ineligible for a traditional heart transplant because of other health problems when doctors at the University of Maryland School of Medicine offered the highly experimental surgery. (Neergaard,10/20)

Abdullah Pratt was only ever interested in science and in sports because of his older brother Rashad. He saw his brother excel at what he did, but Pratt’s life changed in 2012 when his brother was shot and killed in Chicago’s South Side. “The most important thing that his life represented for me was that he relieved me of the burden to prove myself,” Pratt said. (Balthazar, 10/20)

COVID metrics showed more declines last week, though deaths from the virus—one of its severity indicators—rose 4.2% compared to the previous week, the Centers for Disease Control and Prevention (CDC) said in its latest data update. Deaths were up a bit in a number of states but were up more sharply in Oregon. (Schnirring, 10/20)

Scientists hope that by the end of 2024 COVID may become more flu-like but before that fading immunity means more killer waves are on the way. (Axe, 10/23)

�鶹Ů�� Health News: Why Is Finding Covid Shots For Young Children Still So Hard?

On Sept. 12, the Centers for Disease Control and Prevention recommended the next round of covid shots for everyone 6 months and older. The shots were expected to be available within days in pharmacies and doctor’s offices across the country, the CDC said. But more than a month later, the pediatric versions of the new covid shots, for children 6 months to 11 years old, are still difficult to find. A confluence of problems — from technicalities about who can give shots to small kids to the lack of accurate information online on where the kid-sized doses can be found — are still preventing parents from making sure their children are protected. (Fortier, 10/20)

This rollout is the first time the vaccine had entered the commercial market. Before this, the government was paying for and distributing shots. (Rodriguez, 10/23)

When she stopped getting her period in March 2022, Daryn Schwartz wasn’t especially concerned. At 42, she had recently come off birth control, and figured her cycles were still adjusting. When it hadn’t come back by the summer, she sought gynecological care, but was told to wait it out. So she did, with no changes. (Merelli, 10/20)

Adults who were treated with nirmatrelvir–ritonavir (Paxlovid) for their COVID infections in an outpatient setting during the earlier Omicron variant months had a high prevalence of drug-drug interactions (DDIs), Canadian researchers reported yesterday in PLOS One. In its clinical guidance, the Centers for Disease Control and Prevention (CDC) urges healthcare providers to be aware of Paxlovid eligibility criteria and the potential for drug interactions. (Schnirring, 10/20)

“You are not a horse. You are not a cow,” the FDA posted to social media in mid-2021, as COVID-19 vaccines were already widely available in the USA. “Seriously, y’all. Stop it.” Those warnings are now the subject of a pending lawsuit by three doctors who claim the FDA overstepped its authority by weighing in with medical advice they say should be left to physicians. The ivermectin suit is one of several working through federal courts challenging the FDA's power to make decisions or dispense information. (Fritze, 10/23)

A case of locally acquired dengue, a virus transmitted by mosquitoes, was detected in Pasadena on Friday, according to the Pasadena Public Health Department. The instance is “extremely rare,” officials said, with the afflicted person being the first known case in California among someone who had not recently traveled. (Childs, 10/21)

Researchers in the United States have shown for the first time they can safely and effectively infect human volunteers with Zika virus, a step towards learning more about the disease and developing vaccines and treatments. The study – known as a "controlled human infection model" – has previously been controversial for Zika because of the risks to participants and lack of treatments. But U.S. regulators and the World Health Organization ruled the new model, developed by a team at the Johns Hopkins Bloomberg School of Public Health, was safe and scientifically important. (Rigby, 10/21)

Bayer AG must pay $1.25 million to a man who sued the company alleging he developed cancer from exposure to its Roundup weedkiller, a jury in St. Louis, Missouri found Friday. W. Wylie Blair, a lawyer for plaintiff John Durnell, said the verdict broke a winning streak for the company, which had prevailed in the previous nine trials over Roundup. Blair said the trial was the first in which jurors heard evidence that other chemicals in Roundup besides its main ingredient, glyphosate, could cause cancer. (Pierson, 10/20)

In a move cheered by environmentalists and public health groups but opposed by the oil industry, the Biden administration has approved new rules aimed at reducing the amount of air pollution emitted by large ships when they are docked at ports along the state’s coastline. ... That pollution can affect communities in waterfront cities like Oakland, Richmond, Los Angeles, Long Beach and San Diego, increasing the risk of asthma, heart attacks and other health problems. (Rogers, 10/20)

The long overdue EPA finding states clearly that emissions from piston-engine aircraft that use leaded aviation gasoline, known as avgas, are a public health hazard. This finding is an important step toward desperately needed avgas regulation. The Biden Administration’s EPA made the finding after years of advocacy by Earthjustice and other organizations. ... The county study revealed children living near Reid-Hillview faced lead exposure similar to what the residents of Flint, Mich., faced during that city’s 2014 water crisis. (Chavez, 10/21)

Over last two decades, as the principle of sparing health care workers and facilities has continually eroded, the most dangerous incidents have been carried out by state actors, said Michiel Hofman, who is an operational coordinator for Doctors Without Borders in Sudan and a veteran of medical aid delivery in Afghanistan, Yemen and Syria. Yet Article 18 of the First Geneva Convention, ratified by United Nations member states after World War II, says that civilian hospitals “may in no circumstances be the object of attack, but shall at all times be respected and protected by the parties to the conflict.” Article 20 of the convention says that health care workers similarly must be protected by all sides. (Nolen, 10/21)

The only thing worse than the screams of a patient undergoing surgery without enough anesthesia are the terror-stricken faces of those awaiting their turn, a 51-year-old orthopedic surgeon says. ... A shortage of surgical supplies forced some staff to use sewing needles to stitch wounds, which Dr. Nidal Abed said can damage tissue. A shortage of bandages forced medics to wrap clothes around large burns, which he said can cause infections. A shortage of orthopedic implants forced Abed to use screws that don’t fit his patients’ bones. There are not enough antibiotics, so he gives single pills rather than multiple courses to patients suffering terrible bacterial infections. “We are doing what we can to stabilize the patients, to control the situation,” he said. “People are dying because of this.” (Debre andShurafa, 10/21)

At least 130 premature babies are at “grave risk” across six neonatal units, aid workers said. The dangerous fuel shortages are caused by the Israeli blockade of Gaza, which started — along with airstrikes — after Hamas militants attacked Israeli towns on Oct. 7.At least 50,000 pregnant women in Gaza are unable to access essential health services, and some 5,500 are due to give birth in the coming month, according to the World Health Organization. (Shurafa, Magdy and Kullab, 10/22)

The October attacks this year ignited the Israel-Hamas War and spurred the country's startup ecosystem into action. Newer companies are receiving support, from the Israeli government and tech leaders, as well as from U.S.-based healthcare partners. However, anti-Israel sentiment at some U.S. universities threatens long-term relationships between the startups and academic institutions. (Perna, 10/20)

The reauthorization of the President’s Emergency Plan for AIDS Relief (PEPFAR), America’s global initiative to combat HIV, was one of the casualties of the fight to circumvent a government shutdown, with certain authorizations for the program expiring last month. The program can continue to operate into next year with preapproved funding, but advocates worry the damage has already been done to the U.S.’s reputation as a leader in the fight against the HIV epidemic. (Choi, 10/22)

Three publicly traded Chinese drugmakers which count global banks such as UBS and HSBC as investors have used parts of endangered animals as ingredients in their products, an environmental group said. ... The three companies are among a list of 72 firms the environmental non-profit organization (NGO) said used body parts of threatened leopards and pangolins as ingredients in at least 88 traditional Chinese medicine (TCM) products. (Silver andLi, 10/22)

Good doctors are a bit like good detectives. They use their wits, informed by training and experience, to track down the precise cause or causes of a patient’s symptoms and recommend the best treatment. And the clues that physicians follow often come from laboratory tests — of blood or tissue samples, for example. Get the tests right and you can make a diagnosis. If the test results are wrong, though, little else can go right. (10/22)

Early in March 2020, I decided to write about the risks posed by Covid-19. I have no background in epidemiology or even health journalism, but I can multiply, divide and make charts and was frustrated with the lack of quantification in most reporting and public-health messaging on what was soon to be declared a pandemic. (Justin Fox, 10/23)

Two years ago, when my father was dying of dementia, my siblings and I faced a terrible dilemma: Whose wishes for his medical treatment were we to honor? Those of my father back when he was a healthy, highly functioning geneticist? Or those of the simpler, weakened man my father had become? It was a predicament that has led me to rethink my views on advance directives for end-of-life care. (Sandeep Jauhar, 10/23)

Between 1993 and 2013, the number of people 55 or older in state prisons increased by 400 percent. The American Civil Liberties Union estimates that by 2030, people over 55 will constitute a third of the country’s prison population. (Carmilla Floyd, 10/21)

The U.S. preterm birth rate has hit a 15-year high, a startling increase of over 10 percent. This outsized leap is not an anomaly — rather, it is the culmination of a decade-long trend, one that has been particularly dangerous here in the U.S. Today, more than one in every 10 babies are born too early, the second leading cause of infant death (35.8 percent) after birth defects. (Elizabeth Cherot and R. Lawrence Moss, 10/20)

Last week, I joined a number of my fellow colleagues to meet with Gov. Ned Lamont to discuss our concerns regarding Manchester Memorial Hospital, issues with its owner Prospect Medical, and its potential and discussed sale to Yale New Haven Health. We are working with the Governor’s office to ensure the local population is represented in light of the extreme concerns that could arise if Manchester Memorial does not continue the operations its community is accustomed to. (State Sen. MD Rahman, 10/23)